Director, Portfolio Strategy & Market Insights

Director, Portfolio Strategy & Market Insights

The Director, Portfolio Strategy & Market Insights, is a member of the Global Commercial Strategy & Planning team and serves as a strategic advisor to senior leadership. The role leads enterprise-wide investment governance, portfolio prioritization, and decision support to enable long-term growth. The Director also oversees the Market Insights capability, ensuring insights directly inform portfolio decisions, commercial strategy, and resource allocation.

Major Responsibilities:

Strategic Investment Decision Governance

• Leads the design and governance of enterprise-wide investment strategy and portfolio prioritization, shaping critical resource allocation decisions across R&D, capital investments and commercial initiatives to enable delivery of the organization's long-range growth strategy.
• Partners with senior leadership to define investment trade-offs, ensuring alignment to corporate strategy, risk tolerance, and long-term value creation

Portfolio Decision Support

• Leads cross-functional problem solving on high-impact business challenges, defining strategic options and influencing executive decisions
• Challenges faced are often complex with significant ambiguity, requiring extensive investigation and analysis to recommend strategic objectives and alternatives
• Navigate complex matrix business environments and manage diverse stakeholders and their varying interests
• Comfortable with thinking outside the box and bringing unconventional ideas to the table
• Synthesizes complex analyses into clear strategic recommendations, influencing decision-making at the executive level

Market Intelligence, Insights and Strategy

• Maintain surveillance over competitive markets and identify organization strengths and weaknesses and business opportunities
• Sets the global vision and strategic direction for Market Insights, establishing an integrated insights capability that informs enterprise strategy, portfolio decisions, and commercial execution.
• Oversee key market intelligence and insights to provide commercial input to global strategic and regional plans and enable effective strategic, tactical and operational decision-making.
• Direct market research initiatives for insights to forecasting and strategic planning.
• Ensure insights are translated into actionable strategies that directly impact business performance and competitive positioning.

Minimum Qualifications:

• Expertise in business strategy, financial analysis and modelling, decision support and portfolio analysis.
• Undergraduate degree in business, finance, engineering, economics, or science with demonstrated expertise in financial analysis; graduate degree in business or finance preferred
• Typically requires 10-12+ years of relevant experience in strategy, finance, or corporate/business development role, including some experience in the vaccine industry
• Capable of clear communication of sophisticated analytical concepts
• Fluency in conducting and understanding quantitative analysis
• Excellent interpersonal and communication skills, including ability to communicate complicated data clearly and concisely
• Proven ability to work effectively with senior stakeholders
• Native-level fluency in written and spoken English
• Travel Requirements: Up to 20% domestic and international travel as required

Location

• Global - all Seqirus office and site locations

The expected base salary range for this position at hiring is $210,000 - $260,000. Please note this salary range reflects the minimum and maximum base pay that CSL expects to pay for this position in Summit, NJ and Waltham, MA as of the time of this posting. Individual base salary for a successful candidate is determined by qualifications, skill level, experience, competencies and other relevant factors. In addition to base salary, total compensation for this role may also include incentive compensation and equity.

About CSL Seqirus

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.